KalVista Pharmaceuticals, Inc.
KALV
46 insider filings · Latest: Jun 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 27, 2026 | May 29 8:05 PM | Christopher YeaCHIEF DEVELOPMENT OFFICER | Sale | 33,800 | $26.78 | $905.2K | 229,918(D) | View → |
| May 27, 2026 | May 27 9:18 PM | CHRISTOPHER M YEA | Proposed Sale | 33,800 | $26.78 | $905.2K | — | View → |
| May 26, 2026 | May 27 8:05 PM | Christopher YeaCHIEF DEVELOPMENT OFFICER | Sale | 1,966 | $26.78 | $52.6K | 229,918(D) | View → |
| May 26, 2026 | May 27 8:05 PM | Nicole SweenyChief Commercial Officer | Sale | 1,489 | $26.78 | $39.9K | 59,291(D) | View → |
| May 26, 2026 | May 27 8:05 PM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Sale | 2,239 | $26.78 | $60.0K | 150,260(D) | View → |
| May 22, 2026 | May 26 11:35 PM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Sale | 10,926 | $26.78 | $292.6K | 479,989(D) | View → |
| May 22, 2026 | May 26 11:34 PM | Nicole SweenyChief Commercial Officer | Sale | 1,861 | $26.78 | $49.8K | 55,780(D) | View → |
| May 22, 2026 | May 26 11:33 PM | Christopher YeaCHIEF DEVELOPMENT OFFICER | Sale | 2,358 | $26.78 | $63.2K | 228,759(D) | View → |
| May 22, 2026 | May 26 11:33 PM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Sale | 2,685 | $26.78 | $71.9K | 147,499(D) | View → |
| May 22, 2026 | May 26 11:32 PM | Brian PiekosChief Financial Officer | Sale | 1,489 | $26.78 | $39.9K | 21,661(D) | View → |
| May 18, 2026 | May 19 8:05 PM | Christopher YeaCHIEF DEVELOPMENT OFFICER | Sale | 1,108 | $26.76 | $29.7K | 227,367(D) | View → |
| May 18, 2026 | May 19 8:04 PM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Sale | 1,032 | $26.76 | $27.6K | 143,934(D) | View → |
| May 18, 2026 | May 19 8:03 PM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Sale | 1,129 | $26.76 | $30.2K | 467,665(D) | View → |
| May 12, 2026 | May 13 8:25 PM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Sale | 3,322 | $26.71 | $88.7K | 466,375(D) | View → |
| Apr 17, 2026 | Apr 20 11:42 PM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Sale | 2,686 | $20.22 | $54.3K | 142,547(D) | View → |
| Apr 17, 2026 | Apr 20 11:41 PM | Nicole SweenyChief Commercial Officer | Sale | 1,862 | $20.22 | $37.6K | 51,391(D) | View → |
| Apr 17, 2026 | Apr 20 11:40 PM | Brian PiekosChief Financial Officer | Sale | 1,862 | $20.22 | $37.6K | 18,150(D) | View → |
| Apr 17, 2026 | Apr 20 11:40 PM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Sale | 9,550 | $20.22 | $193.1K | 462,577(D) | View → |
| Mar 26, 2026 | Mar 27 9:50 PM | Venrock Healthcare Capital Partners III, L.P.10% Owner | Sale | 39,986 | $18.28 | $730.8K | 5,089,354(I) | View → |
| Mar 25, 2026 | Mar 27 9:50 PM | Venrock Healthcare Capital Partners III, L.P.10% Owner | Sale | 174,645 | $16.95 | $3.0M | 5,129,340(I) | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | May 26 11:33 PM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Option Exercise | 6,250 | — | 68,750(D) | View → |
| May 21, 2026 | May 26 11:32 PM | Brian PiekosChief Financial Officer | Option Exercise | 5,000 | — | 55,000(D) | View → |
| May 17, 2026 | May 19 8:05 PM | Christopher YeaCHIEF DEVELOPMENT OFFICER | Option Exercise | 1,774 | — | 0(D) | View → |
| May 17, 2026 | May 19 8:04 PM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Option Exercise | 2,419 | — | 0(D) | View → |
| May 17, 2026 | May 19 8:03 PM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 2,419 | — | 0(D) | View → |
| May 11, 2026 | May 13 8:25 PM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 7,120 | — | 92,560(D) | View → |
| Apr 16, 2026 | Apr 20 11:42 PM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Option Exercise | 6,250 | — | 93,750(D) | View → |
| Apr 16, 2026 | Apr 20 11:41 PM | Nicole SweenyChief Commercial Officer | Option Exercise | 6,250 | — | 93,750(D) | View → |
| Apr 16, 2026 | Apr 20 11:40 PM | Brian PiekosChief Financial Officer | Option Exercise | 6,250 | — | 93,750(D) | View → |
| Apr 16, 2026 | Apr 20 11:40 PM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 20,312 | — | 304,688(D) | View → |
| Mar 6, 2026 | Mar 10 10:47 PM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 15,625 | — | 125,001(D) | View → |
| Feb 22, 2026 | Feb 25 12:44 AM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Option Exercise | 5,000 | — | 45,000(D) | View → |
| Feb 21, 2026 | Feb 25 12:44 AM | Paul K. AudhyaCHIEF MEDICAL OFFICER | Option Exercise | 6,250 | — | 75,000(D) | View → |
| Feb 21, 2026 | Feb 25 12:44 AM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 23,250 | — | 279,000(D) | View → |
| Feb 22, 2026 | Feb 25 12:43 AM | Christopher YeaCHIEF DEVELOPMENT OFFICER | Option Exercise | 3,125 | — | 28,125(D) | View → |
| Feb 21, 2026 | Feb 25 12:43 AM | Christopher YeaCHIEF DEVELOPMENT OFFICER | Option Exercise | 3,750 | — | 45,000(D) | View → |
| Feb 22, 2026 | Feb 25 12:42 AM | Nicole SweenyChief Commercial Officer | Option Exercise | 5,000 | — | 45,000(D) | View → |
| Feb 21, 2026 | Feb 25 12:42 AM | Nicole SweenyChief Commercial Officer | Option Exercise | 6,250 | — | 75,000(D) | View → |
| Feb 21, 2026 | Feb 25 12:42 AM | Brian PiekosChief Financial Officer | Option Exercise | 5,000 | — | 60,000(D) | View → |
| Feb 17, 2026 | Feb 20 12:45 AM | Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 2,419 | — | 2,419(D) | View → |